The previous page is sending you to http://www.marketwatch.com/story/fda-advisory-committee-unanimously-recommends-approval-of-mercks-vytorinr-ezetimibesimvastatin-for-use-in-patients-with-pre-dialysis-chronic-kidney-disease-2011-11-02.

 If you do not want to visit that page, you can return to the previous page.